AbCellera (ABCL) Tops Q1 EPS by 24c

AbCellera (NASDAQ: ABCL) reported Q1 EPS of $0.54, $0.24 better than the analyst estimate of $0.30. Revenue for the quarter came in at $317 million versus the consensus estimate of $179.95 million.

For earnings history and earnings-related data on AbCellera (ABCL) click here.

You May Also Be Interested In

• Goldman Sachs Resumes AbCellera Biologics (ABCL) at Neutral
• B. Riley’s Top Biotech Picks Ahead of 3Q26 Earnings Season
• S&P downgrades Cable One to ’B+’ on weakening broadband outlook